Correlation Between Processa Pharmaceuticals and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Processa Pharmaceuticals and AN2 Therapeutics, you can compare the effects of market volatilities on Processa Pharmaceuticals and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and AN2 Therapeutics.
Diversification Opportunities for Processa Pharmaceuticals and AN2 Therapeutics
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Processa and AN2 is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Processa Pharmaceuticals and AN2 Therapeutics
Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the AN2 Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Processa Pharmaceuticals is 1.19 times less risky than AN2 Therapeutics. The stock trades about -0.28 of its potential returns per unit of risk. The AN2 Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 110.00 in AN2 Therapeutics on August 28, 2024 and sell it today you would earn a total of 29.00 from holding AN2 Therapeutics or generate 26.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Processa Pharmaceuticals vs. AN2 Therapeutics
Performance |
| Timeline |
| Processa Pharmaceuticals |
| AN2 Therapeutics |
Processa Pharmaceuticals and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Processa Pharmaceuticals and AN2 Therapeutics
The main advantage of trading using opposite Processa Pharmaceuticals and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
| AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. HCW Biologics | AN2 Therapeutics vs. Scpharmaceuticals | AN2 Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |